FDA says Taco Bell to stop using lettuce supplier linked to multistate parasite outbreak
The FDA advised consumers in five states not to eat shredded iceberg lettuce from Mexico served at Taco Bell as the cyclosporiasis outbreak grows.
Healthcare could become an early AI 'winner,' strategist says
U.S. Bank Asset Management Group senior investment strategist Rob Haworth discusses healthcare as a lagging sector benefiting from A.I. advancements on 'The Claman Countdown.'
Tom Brady teams with digital health firm eMed to expand GLP-1 weight loss medication access
NFL legend Tom Brady is partnering with eMed to tackle the obesity epidemic by making GLP-1 weight loss medications accessible through employer health benefits.
Obamacare exchange flaw exposed Americans to unexpected health plan switches, watchdog finds
The GAO found that the federal Obamacare exchange lacked safeguards for consumers and allowed unscrupulous agents and brokers to make unauthorized enrollments or plan changes.
Taco Bell investigated as lettuce emerges as possible source of cyclosporiasis outbreak
Federal and state health agencies are reportedly reviewing whether Taco Bell locations contributed to the cyclosporiasis outbreak sweeping Michigan and America.
FDA moves to expose hidden foreign drug factories, strengthen domestic production in sweeping rule proposal
The FDA's new website and regulatory overhaul aim to close a loophole that lets foreign factories hide raw drug materials from U.S. supply chain oversight.
AI will be 'transformational' in drug development and discovery, Pfizer CEO says
Pfizer CEO Albert Bourla details $70B US investment in manufacturing and R&D, discussing oncology advancements, the GLP-1 drug race, and AI's transformative role in drug development on 'Mornings with Maria.'
Top tobacco company to cut thousands of jobs
British American Tobacco plans to cut 5,500 jobs and outsource 3,500 roles as it uses AI to reshape operations amid declining traditional tobacco sales.
The overlooked reason why new drugs take so long—and the $10 trillion fix
A new report estimates speeding up FDA drug approvals by one year could generate over $10 trillion in economic value from faster medical innovation.
Nearly 1 million bottles of heart and kidney medication recalled over foreign substance found on tablets
Amgen recalled nearly one million bottles of Corlanor and Sensipar tablets after unexpected foreign matter was found on tablet surfaces during sampling.
US shoulders disproportionate cost of new medications, report finds
A new Office of Health Policy report reveals Americans shoulder a disproportionate share of prescription drug costs, covering nearly 80% of innovative revenue for new medications.
Thousands of bottles of blood pressure medication recalled nationwide
Over 11,000 bottles of chlorthalidone blood pressure medication are being recalled nationwide due to failed dissolution specifications, according to the FDA.
CDC urges parents to stop using Nara Organics infant formula after three babies hospitalized with botulism
CDC urges parents to immediately stop using Nara Organics infant formula after three babies were hospitalized with botulism in multiple states.
Nicotine pouches surge in popularity as Diplo, celebrity investors bet on industry's future
Nicotine pouches are experiencing explosive growth in the U.S., with monthly sales surging nearly 251% since early 2023, a study showed.
Popular pet food brand halts production after FDA warns of possible dangerous contamination
Raaw Energy is recalling dozens of frozen raw dog food products sold in nine states over Listeria concerns, according to an FDA notice issued Friday.
Hosting a Memorial Day cookout? Here's how much it could cost
Memorial Day grilling costs are notably higher as inflation data shows beef, hot dogs, and fresh vegetables all saw significant year-over-year increases.
Three major hospital systems accuse CVS of secretly siphoning hundreds of millions in drug savings
Three major hospital systems have accused CVS of allegedly diverting hundreds of millions from the federal 340B Drug Pricing Program.
Asbestos fears spark urgent recall of 120K+ squeeze toys sold at Walmart, Ollie’s
The Orb Factory recalled more than 121,000 squeeze toys nationwide after tests found fibrous tremolite, a form of asbestos, inside the products.
Bel North America CEO reveals 'north star' on snacking: 'Democratize better options'
Bel North America CEO Peter McGuinness joins 'Mornings with Maria' to discuss the company's push for healthy snacking options, the big bet on protein snacks and the investment in US production.
Mark Cuban joins forces with Trump on major TrumpRX expansion
‘The Big Money Show’ panel reacts to President Donald Trump’s major TrumpRX expansion and Mark Cuban partnership aimed at lowering prescription drug costs for Americans.


















